medRxiv
medrxiv.org
- Free plan
- Web
- API
What medRxiv is
medRxiv is a free web and API archive for unpublished preprints in medical, clinical and related health sciences. Authors can register and deposit eligible manuscripts without a submission fee, while readers can retrieve posted articles at no charge. Accepted content includes original research, systematic reviews and meta-analyses, data articles, methodological research and clinical research design protocols. Manuscripts must be in English, and case reports or case series are not accepted. Articles are available as PDF, full-text HTML and XML, with supplemental files kept in their submitted formats. Search covers article text, with advanced filters for title, authors, abstract, full text, article type and subject area. Each preprint shows abstract and PDF views plus Altmetric attention, updated daily. APIs and feeds support machine analysis. Authors can submit from the author area to integrated journals; the FAQ lists 144. Screening checks issues such as plagiarism, ethics, trial registration and potentially harmful content, but preprints are not peer reviewed before posting.
Who it suits
It is for researchers sharing eligible medical or health-science manuscripts and readers seeking openly accessible preprints. It also suits users needing searchable full text or machine access through APIs and feeds.
Good to know, and what to watch
- Free submission and reader access
- PDF, HTML and XML article formats
- Advanced search filters
- Daily usage and Altmetric metrics
- APIs and feeds for machine analysis
- Preprints lack peer review before posting
- Manuscripts must be in English
- Case reports and case series are excluded
- Not intended to guide clinical practice
Plans
Every plan and priceFree access and submission
Free plan
The verdict
medRxiv provides no-cost distribution and access for specified medical preprints. Readers should treat postings as unreviewed research rather than clinical guidance.
What the maker publishes
- API and bulk access
- The FAQ states that medRxiv provides free and unrestricted access to all posted articles and that APIs and feeds facilitate machine analysis. source
- Article formats
- Preprints are available as PDF, full-text HTML, and XML, while supplemental files are available in their submitted formats. source
- Eligible content
- The server accepts original research articles, systematic reviews and meta-analyses, data articles, methodological research, and clinical research design protocols. source
- Founded
- 2019 source
- Journal transfers
- Authors can submit preprints directly to an increasing number of journals from the author area, and the FAQ reports 144 integrated journals at the time of its page content. source
- Metrics
- Each preprint has metrics for abstract and PDF views and Altmetric attention, with usage updated daily. source
- Peer review
- Preprints are not certified by peer review before posting and should not be relied on to guide clinical practice or health-related behavior. source
- Purpose
- medRxiv is a free online archive and distribution server for unpublished preprints in medical, clinical, and related health sciences. source
- Reader access
- Posted preprints are retrievable through the web interface at no charge. source
- Screening
- Submissions are screened for offensive or non-scientific content and material that might pose a health risk. source
- Screening safeguards
- Screening checks include plagiarism, article suitability, ethical oversight, clinical trial registration, identifying information, and content that could endanger patients or the public. source
- Search
- Simple search covers article full text, and advanced search can restrict results by title, authors, abstract, full text, article type, or subject area. source
- Submission fee
- There is no charge for registration or manuscript deposition. source
- Submission limits
- Manuscripts must be submitted in English, and case reports or case series are not accepted. source
- Support
- The manuscript processing system lists [email protected] as its contact email. source
Checked against the maker's pages on 8 Oct 2026.